A phase 2 trial is being conducted after findings showed safety of the gene therapy product and stabilization or improvement in severity of patients’ condition at 12 months post-treatment.
Phase 1 data for a new gene therapy heart failure…
A phase 2 trial is being conducted after findings showed safety of the gene therapy product and stabilization or improvement in severity of patients’ condition at 12 months post-treatment.
Phase 1 data for a new gene therapy heart failure…